BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical, and life sciences sectors.
BNN | F
Overview
Corporate Details
- ISIN(s):
- DE0005203947 (+1 more)
- LEI:
- 391200JKPVHLD6JLZ107
- Country:
- Germany
- Address:
- Darmstädter Straße 34-36, 64673 Zwingenberg
- Website:
- https://www.brain-biotech.com/
Description
BRAIN Biotech AG is an industrial biotechnology company specializing in the discovery, development, and production of specialty enzymes, high-performance microorganisms, and bioactive compounds. The company provides tailor-made biosolutions and contract research and development (R&D) services to partners in the food, chemical, and life sciences sectors. Core competencies include enzyme technology, microbial strain development, and bioprocess development. By leveraging an advanced technology portfolio, which includes proprietary platforms for enzyme discovery and genome editing, the company enables its partners to create more sustainable and efficient industrial products and processes, contributing to the bioeconomy.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-11 18:47 |
BRAIN Biotech AG: BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology
|
English | HTML • 7.7 KB | ||
| 2022-01-10 15:43 | English | HTML • 4.3 KB | |||
| 2022-01-10 00:00 |
Hinweis auf Jahresfinanzbericht vom 01.10.2020 bis zum 30.09.2021
|
German | HTML • 5.8 KB | ||
| 2021-12-08 15:00 |
BRAIN Biotech AG: Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (…
|
English | HTML • 10.8 KB | ||
| 2021-12-08 14:53 |
BRAIN Biotech AG: Additional Differentiated Genome-Editing Nuclease: BRAIN-Meta…
|
English | HTML • 7.4 KB | ||
| 2021-11-03 10:00 |
BRAIN Biotech AG: BRAIN and SAMS apply BEC gene-editing technology to Omega-3 C…
|
English | HTML • 13.7 KB | ||
| 2021-09-16 19:30 |
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | HTML • 4.3 KB | ||
| 2021-09-15 21:51 |
BRAIN Biotech AG successfully placed new share capital for the financing of fur…
|
English | HTML • 9.8 KB | ||
| 2021-09-15 21:48 |
BRAIN Biotech AG: BRAIN Biotech AG has successfully completed 10% cash capital …
|
English | HTML • 15.9 KB | ||
| 2021-09-15 17:45 |
BRAIN Biotech AG resolves on a cash capital increase from authorised capital
|
English | HTML • 9.7 KB | ||
| 2021-09-15 17:40 |
BRAIN Biotech AG resolves on a 10% cash capital increase from authorised capita…
|
English | HTML • 17.0 KB | ||
| 2021-09-03 14:00 |
Capital Markets Day BRAIN Biotech AG: Focus on BEC Technology and its Transform…
|
English | HTML • 13.1 KB | ||
| 2021-09-03 13:32 | English | HTML • 14.2 KB | |||
| 2021-09-03 13:21 | English | HTML • 19.1 KB | |||
| 2021-09-01 10:00 |
BRAIN Biotech AG: BRAIN appoints University of Leiden as partner for BEC-Enable…
|
English | HTML • 13.1 KB |
Automate Your Workflow. Get a real-time feed of all BRAIN Biotech AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BRAIN Biotech AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BRAIN Biotech AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-03 | Schneiders, Michael | Board | Buy | None | 25,000.00 EUR |
| 2025-01-16 | Moelker, Adriaan | Board | Buy | None | 35,795.96 EUR |
Peer Companies
